ADVATx-LASER is a fractional laser equipped with two wavelengths, 589nm and 1319nm. It is characterized by its ability to address a wide range of skin concerns, from facial redness and inflammatory acne to visible pores, sebum-related concerns, and improved skin firmness through the promotion of collagen production.
It has received FDA (U.S. Food and Drug Administration) approval for 25 diseases and conditions, and its efficacy and safety as a medical device have been internationally recognized. In Japan, its applications are also expanding for conditions that have been difficult to address with conventional treatments, including rosacea, acne scars with residual redness, and enlarged pores, and it is becoming established as an option in cosmetic dermatology.
A feature of ADVATx-LASER is its flexibility not only in wavelength selection but also in the “irradiation method.” With standard irradiation, either 589nm or 1319nm is delivered evenly across the entire face, with the goal of improving overall redness and skin quality.
For areas with particularly strong redness, such as part of the cheeks or around the nose, 589nm may instead be delivered in spots at a somewhat higher output. In this case, redness or mild swelling may occur in the treated areas for approximately 2–3 days, and the expected downtime may be longer than with standard uniform irradiation.
If you undergo treatment based only on the understanding that it is a “treatment with limited downtime,” you may feel a gap when this irradiation method is selected. It is therefore important to confirm the treatment plan thoroughly during your consultation. Details are explained in the following article.